Patients of 75 years and over with ANCA‐associated vasculitis have a lower relapse risk than younger patients: A multicentre cohort study

Abstract

AAV patients ≥75 years have a lower relapse risk than patients aged 65-75 years despite a lower probability of having received maintenance therapy with a combination of glucocorticoids and immunosuppressants, but they still benefit from such treatment regimen.